title: A novel germ line juxtamembrane Met mutation in human gastric cancer.
abstract: Activating mutations in the Met receptor tyrosine kinase, both germline and somatic, have been identified in human papillary renal cancer. Here we report a novel germline missense Met mutation, P1009S, in a patient with primary gastric cancer. The dosage of the mutant Met DNA was elevated in the tumor when compared to its matched normal DNA. Therefore, as with hereditary renal papillary cancer, the mutant Met allele may also be selectively duplicated in the tumor. Different from previously reported Met mutations, which occur in the tyrosine kinase domain, this missense mutation is located at the juxtamembrane domain, and is not constitutively activated. However, following treatment with HGF/SF, the P1009S mutant Met protein, expressed in NIH3T3 cells, displays increased and persistent tyrosine phosphorylation compared to the wild-type Met. Importantly, these cells also form colonies in soft agar, and are highly tumorigenic in athymic nude mice. A second nucleotide change in this region of Met, T1010I, was found in a breast cancer biopsy and a large cell lung cancer cell line. Although this previously reported 'polymorphism' did not stimulate NIH3T3 cell growth in soft agar, it was more active than the wild-type Met in the athymic nude mice tumorigenesis assay, suggesting that it may have effects on tumorigenesis. Met has been shown to be highly expressed in human gastric carcinoma cell lines, and our results raise the possibility that activating missense Met mutations could contribute to tumorigenesis of gastric cancer.
authors.affiliation: NCI-Frederick Research and Development Center, P.O. Box B, Frederick, Maryland, MD 21702, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Lee
authors.forename: S U
authors.initials: SU
authors.lastname: Han
authors.forename: H
authors.initials: H
authors.lastname: Cho
authors.forename: B
authors.initials: B
authors.lastname: Jennings
authors.forename: B
authors.initials: B
authors.lastname: Gerrard
authors.forename: M
authors.initials: M
authors.lastname: Dean
authors.forename: L
authors.initials: L
authors.lastname: Schmidt
authors.forename: B
authors.initials: B
authors.lastname: Zbar
authors.forename: G F
authors.initials: GF
authors.lastname: Vande Woude
mesh_terms: D016475:3T3 Cells / Q000378:metabolism; D000230:Adenocarcinoma / Q000235:genetics*; D000595:Amino Acid Sequence; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D004273:DNA, Neoplasm / Q000235:genetics; D005091:Exons; D005260:Female; D005784:Gene Amplification; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D018095:Germ-Line Mutation; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D010766:Phosphorylation / Q000187:drug effects; D017434:Protein Structure, Tertiary; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics* / Q000378:metabolism; D013274:Stomach Neoplasms / Q000235:genetics*; D014443:Tyrosine / Q000378:metabolism
chemical_list: D004273:DNA, Neoplasm; D014443:Tyrosine; D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met